CIK 0001472012 · Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770694340
- Phone
- 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 56 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | Higgins Jack Chief Scientific Officer | Gift | +1,000 | 1,000 | ||
| 2025-12-19 | Higgins Jack Chief Scientific Officer | Gift | −1,000 | 37,729 | ||
| 2025-12-19 | Higgins Jack Chief Scientific Officer | Gift | +1,000 | 1,000 | ||
| 2025-12-19 | SIEGALL CLAY B President and CEO | Purchase | +7,278 | $20.48 | $149K | 860,525 |
| 2025-12-19 | SIEGALL CLAY B President and CEO | Gift | −200,000 | 660,525 | ||
| 2025-12-18 | SIEGALL CLAY B President and CEO | Purchase | +46,511 | $21.50 | $1000K | 853,247 |
| 2025-09-10 | Higgins Jack Chief Scientific Officer | Option exercise | +22,000 | $1.35 | $30K | 40,729 |
| 2025-09-10 | Higgins Jack Chief Scientific Officer | Option exercise · Employee Stock option (right to buy) | −22,000 | 151,840 | ||
| 2025-07-29 | Tsai Philip Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2025-07-29 | Rosett Max Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +207,000 | 207,000 | ||
| 2025-07-29 | Lechleider Robert Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +242,000 | 242,000 | ||
| 2025-07-29 | Horn Kinney CHIEF BUSINESS OFFICER | Grant or award · Employee Stock Option (right to buy) | +161,000 | 161,000 | ||
| 2025-07-29 | Higgins Jack Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +196,000 | 196,000 | ||
| 2025-07-29 | SIEGALL CLAY B President and CEO | Grant or award · Employee Stock Option (right to buy) | +800,000 | 800,000 | ||
| 2025-07-29 | Stoneman Sandra G. CHIEF LEGAL OFFICER & GC | Grant or award · Employee Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2025-06-10 | Boylan James P Director | Grant or award · Director Stock Option (right to buy) | +18,864 | 18,864 | ||
| 2025-06-10 | SCHAFER CAROL Director | Grant or award · Director Stock Option (right to buy) | +18,864 | 18,864 | ||
| 2025-06-10 | WAGENHEIM PHILIP Director | Grant or award · Director Stock Option (right to buy) | +18,864 | 18,864 | ||
| 2025-06-10 | Barchas Isaac Director | Grant or award · Director Stock Option (right to buy) | +18,864 | 18,864 | ||
| 2025-06-10 | BIENAIME JEAN JACQUES Director | Grant or award · Director Stock Option (right to buy) | +18,864 | 18,864 |
Page 5 of 8 · 159 trades